In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Late-Breaking Science in Heart Failure
2017 Session

Congress : ESC CONGRESS 2017

Topic : Chronic Heart Failure - Other

  • Session type : Late-Breaking Science
  • Date : 28 August 2017
  • Time : 08:30 - 10:00
15 views

6 presentations in this session

2017

Efficacy of beta-blockers in heart failure according to left ventricular ejection fraction: An individual patient level analysis of double-blind randomised trials

Congress : ESC Congress 2017

  • Session : Late-Breaking Science in Heart Failure
  • Speaker : D Kotecha (Birmingham,GB)
2017

Marked variation in the efficacy of beta-blockers across cardiovascular health: A Global systematic assessment of mortality, myocardial infarction and stroke

Congress : ESC Congress 2017

  • Session : Late-Breaking Science in Heart Failure
  • Speaker : O Ziff (London,GB)
2017

Heart Failure-Wii study

Congress : ESC Congress 2017

  • Session : Late-Breaking Science in Heart Failure
  • Speaker : T Jaarsma (Norrkoping,SE)
2017

Predicting right heart failure after implantation of continuous flow left ventricular assist devices (EUROMACS-RHF) score: analysis of the EUROMACS data

Congress : ESC Congress 2017

  • Session : Late-Breaking Science in Heart Failure
  • Speaker : OII Soliman (Rotterdam,NL)

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, and Novartis Pharma AG. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are